What You Should Know:
– Ambience Healthcare, the leading enterprise AI platform for documentation, CDI & coding, and care coordination, today announced an agreement with athenahealth, Inc through the company’s Marketplace program.
– As part of…
Continue Reading
What You Should Know:
– Abridge, a provider of generative AI solutions for healthcare launches Abridge Inside for Emergency Medicine, a new suite of enhancements designed specifically for the fast-paced and demanding environment of emergency…
Continue Reading
What You Should Know:
– ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their…
Continue Reading
Revolutionary Healthcare Partnership Announced
GE HealthCare Technologies Inc. and the University of California San Francisco’s Department of Radiology and Biomedical Imaging have joined forces in a landmark partnership focusing on advanced imaging and precision oncology…
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
Dr. Rakesh Nagarajan is the Chief Medical Officer at Velsera
The healthcare industry is experiencing a data and technological revolution that is accelerating drug discovery and delivery to patients. Over the past 15 years, we’ve…
Continue Reading
Background: HIV continues to be a public health concern for Mexico and Latin America due to an increase in new cases, instead of a decrease, such as is observed globally. Treatment adherence is a…
Continue Reading
Rare diseases, affecting ~350 million people worldwide, pose significant challenges in clinical diagnosis due to the lack of experienced physicians and the complexity of differentiating between numerous rare diseases. To address these challenges, we…
Continue Reading
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer’s disease and test that device in clinical trials.The…
Continue Reading
What You Should Know:
– Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.
– The company’s latest advancement integrates a…
Continue Reading
